The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
Gestational diabetes mellitus (GDM) represents a key metabolic complication of pregnancy, carrying significant implications for both maternal and offspring ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime insulin to improve glycemic control.
Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
One day, there could be a new test to screen for type 1 diabetes, now that scientists have found markers in the blood of the ...
1don MSN
Beyond the brand names: Everything you need to know about Ozempic and other GPL-1 medications
Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...
MannKind (Nasdaq:MNKD) announced today that it received FDA approval, updating the prescribing information for Afrezza ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results